BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,419,000 | -18.4% | 16,128,515 | 0.0% | 0.14% | -36.5% |
| Q4 2018 | $1,740,000 | -43.2% | 16,128,515 | 0.0% | 0.22% | -28.2% |
| Q3 2018 | $3,064,000 | -14.0% | 16,128,515 | 0.0% | 0.31% | -32.7% |
| Q2 2018 | $3,561,000 | -4.4% | 16,128,515 | 0.0% | 0.46% | -13.1% |
| Q1 2018 | $3,726,000 | +145.0% | 16,128,515 | +16.9% | 0.53% | +62.0% |
| Q4 2017 | $1,521,000 | -62.3% | 13,799,944 | -2.1% | 0.33% | -60.0% |
| Q3 2017 | $4,032,000 | -40.3% | 14,096,338 | 0.0% | 0.82% | -52.1% |
| Q2 2017 | $6,752,000 | +4.3% | 14,096,338 | +10.0% | 1.70% | -10.7% |
| Q1 2017 | $6,471,000 | +35.0% | 12,814,286 | 0.0% | 1.90% | +20.6% |
| Q4 2016 | $4,793,000 | – | 12,814,286 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 12,814,286 | $6,471,000 | 1.90% |
| RTW INVESTMENTS, LP | 1,283,951 | $648,000 | 0.17% |
| Sio Capital Management, LLC | 313,717 | $158,000 | 0.09% |
| DAFNA Capital Management LLC | 115,000 | $58,000 | 0.05% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 28,027 | $14,000 | 0.00% |
| Baker Brothers Advisors | 377,295 | $191,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,994 | $55,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,797,000 | 0.00% |
| Moors & Cabot, Inc. | 13,000 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,274 | $8,000 | 0.00% |